Potassium channel activators work through two mechanisms. Firstly, they activate ATP-sensitive potassium channels leading to vasodilation of coronary vessels. Secondly, they act in a similar manner to nitrates by activating guanylyl cyclase and producing an increase the cGMP levels in vascular smooth muscle cells. This leads to vasodilatation in coronary vessels and also in the venous and arterial systems, leading to a reduction in preload, afterload, and hence myocardial oxygen consumption.